Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)

• Status: Not yet recruiting
• Trial end date: 2024-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the use of aromatherapy to reduce nausea, vomiting, and the use of anti-emetic in cancer survivors undergoing moderate to highly emetogenic chemotherapy regimens.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Miami

Criteria

Inclusion Criteria:

1. 18 years of age or older

2. Able to read and speak English or Spanish

3. Able to and willing to give informed consent

4. Currently undergoing moderate and high emetogenic chemotherapy (adjuvant or neoadjuvant)

5. Receiving three or more remaining cycles of chemotherapy

6. Symptoms of nausea or vomiting after the first chemotherapy infusion

Exclusion Criteria:

1. Unable or unwilling to give informed consent

2. Sensitivity to essential oils*

3. Olfactory disorders

4. Receiving chemotherapy for the first time

5. Undergoing low emetogenic chemotherapy regimens

6. Patients with hormone-sensitive cancers

7. Timely request of treating provider